广州安必平医药科技股份有限公司关于自愿披露公司及子公司2025年10-12月获得资质情况的公告

Group 1 - The company and its subsidiaries obtained 9 domestic medical device registration certificates, 3 intellectual property qualifications, and 1 overseas qualification from October to December 2025 [1] - The acquisition of these qualifications will enrich the company's product variety, enhance its intellectual property protection system, expand its product layout in the fields of tumor screening and precision diagnosis, and strengthen its core competitiveness [1]